Skip to main content

Table 2 Treatment characteristics

From: Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: A phase II-study (NCT00356161)

Number of patients

70

Number of treatment cycles

562

 Range

1-34

 Mean

8

Reason for termination of HAI

 

 Disease progression (intrahepatic n=11, extrahepatic n=16, both n=17)

44 (63%)

 Chemotherapy-related toxicity

12 (17%)

 Port complication

5 (7%)

 Post-progression HAI

4 (6%)

 Refusal

4 (6%)

 Loss of follow up

1 (1%)

Port complications per patient

 

 ≥1 complication

21 (30%)

 ≥3 complications

3 (4%)

 ≥ 1 revision

15 (21%)